2,679 results
P
adolescents
I/C
therapies specifically aimed at reducing NSSI
O
NSSI reduction, global functioning change, depressive symptomatology reduction
P
young adults
I/C
cognitive and behavioral interventions aimed at improving sleep, randomized-controlled trials (RCTs)
O
anxiety and depression
P
atavistic reversal, cancer attractor, somatic mutation, genome chaos, tissue organization field
I/C
gradual atavism, serial atavism, random alterations in cellular networks
O
selfish cell behavior aimed at survival at all means
P
people diagnosed with TB
I/C
interventions to increase TB treatment adherence, no intervention
O
TB treatment completion
P
COVID-19 patients
I/C
3-drugs-3-formulas, conventional treatment
O
duration of fever, cough, fatigue, length of hospital stay, time for nucleic acid conversion, aggravation rate, mortality, recovery rate of chest computerized tomography manifestations, total effectiveness
P
surgical patients
I/C
goal-directed hemodynamic therapy (GDHT), different GDHTs
O
30-day mortality, acute kidney injury (AKI), arrhythmia
P
patients with end-stage kidney disease
I/C
Renal transplantation, AKI kidneys
O
delayed graft function (DGF) and primary non-function (PNF)
P
pancreatic insulinoma
I/C
endoscopic ultrasound (EUS)-guided ablation, minimally invasive surgery (MIS), adverse events (AEs), clinical and technical success rates, length of hospital stays, symptom recurrence rates
O
lower AE rate, shorter length of hospital stay, higher recurrence rate
P
individuals exposed to hypoxia
I/C
exercise under hypoxia, none
O
cognitive function
P
older adults
I/C
non-pharmacological interventions, multi-component interventions
O
delirium prevention